The effect of Low-dose Aspirin in the Prevention of Gastric Cancer
Phase 3
- Conditions
- Gastric Cancer.Malignant neoplasm of stomach
- Registration Number
- IRCT201105082032N3
- Lead Sponsor
- Ministry of Health and Medical Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 21000
Inclusion Criteria
Living in the province for ten years
Negative pregnancy test
Willing to participate in the study
Willing to provide biological specimens
Willing to sign an informed consent form
Exclusion Criteria
No history of Gastric cancer
History of Severe dyspepsia, peptic ulcer and GI bleeding/ perforation
History of NSAID gastritis
Known allergy to any of the study medications
Known medical conditions that could limit life expectancy (eg. HIV/AIDS, congestive heart failure, renal failure, hepatic failure, current or prior malignancy, any other chronic disease that limits function)
Prior esophageal malignancy, gastric ulcer or a gastrectomy (full or partial)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastric Cancer. Timepoint: visits at first, 12 weeks, every 4 months, 5 years and 10 years. Method of measurement: Age standardized Incidence and Mortality Rate.
- Secondary Outcome Measures
Name Time Method